Control and surveillance of human African trypanosomiasis.
about
Detection and identification of pathogenic trypanosome species in tsetse flies along the Comoé River in Côte d'IvoireImmune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to PathogenicityOverview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness")Epidemiology of human African trypanosomiasisA targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’IvoireA panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection modelsPredicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of CongoTrypanosoma brucei Invasion and T-Cell Infiltration of the Brain Parenchyma in Experimental Sleeping Sickness: Timing and Correlation with Functional ChangesDiscovery of a Carbazole-Derived Lead Drug for Human African TrypanosomiasisAssembling a geospatial database of tsetse-transmitted animal trypanosomosis for AfricaMapping landscape friction to locate isolated tsetse populations that are candidates for eliminationForecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models.MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African TrypanosomosisAntiviral drug valacyclovir treatment combined with a clean feeding system enhances the suppression of salivary gland hypertrophy in laboratory colonies of Glossina pallidipes.Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasisMonitoring the elimination of human African trypanosomiasis: Update to 2014Recombinant antigens expressed in Pichia pastoris for the diagnosis of sleeping sickness caused by Trypanosoma brucei gambiense.Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.First WHO meeting of stakeholders on elimination of gambiense Human African Trypanosomiasis.Diagnostic work-up of neurological syndromes in a rural African setting: knowledge, attitudes and practices of health care providers.The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes.Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa.Optimal strategies for controlling riverine tsetse flies using targets: a modelling study.On the road to elimination of Rhodesiense human African trypanosomiasis: first WHO meeting of stakeholders.From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.Tsetse fly (G. f. fuscipes) distribution in the Lake Victoria basin of UgandaHuman African trypanosomiasis presenting at least 29 years after infection--what can this teach us about the pathogenesis and control of this neglected tropical disease?Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis.Reducing Human-Tsetse Contact Significantly Enhances the Efficacy of Sleeping Sickness Active Screening Campaigns: A Promising Result in the Context of Elimination.Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics.Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and riskMolecular evidence of a Trypanosoma brucei gambiense sylvatic cycle in the human african trypanosomiasis foci of Equatorial GuineaGMP synthase is essential for viability and infectivity of Trypanosoma brucei despite a redundant purine salvage pathway.Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads.Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo.Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasisTreatment options for second-stage gambiense human African trypanosomiasis.An atlas of tsetse and bovine trypanosomosis in Sudan.
P2860
Q22810158-6EB428B1-AC13-4B06-A36C-41EA8CC805D2Q26742172-E6B87B12-3639-425D-8B48-C31A2479377AQ26778571-5C3212C1-E5D5-4873-B942-B5006D99E728Q26826895-BE151FC4-869E-47AE-BF99-86C7ACF7D45AQ27026504-574FC835-D741-4F0B-9B50-44A99C5C24DCQ27926217-400D78D1-920C-4B10-B3C1-F39F181D33A1Q28542468-CCCFC88C-98A2-47C2-BC17-62A601B08ADAQ28555206-119DF057-EA60-4FA1-90F5-4951989B115DQ28555225-5A770BE5-7B3C-45F1-98EE-2935179B2E60Q28828834-27729E69-F4E5-44CA-8DF0-D3C90A1F521DQ30577749-6E9BA15D-4911-4C61-AA4A-D8532B0748ACQ31020669-E4D1A11C-4A88-4429-8F28-DC3A296C8A78Q31132495-DB7819B5-8E54-402C-81D3-0EBD23BD0664Q33435381-C05FF8F1-8EEA-40EB-BFE4-E093E7261FDBQ33634240-A0B8F7E1-2AF4-4437-9D18-D17900D9F0BDQ33681753-761DAA89-86A6-41D9-B527-74A8F01EF1C6Q33751576-AF65BC8C-7AB4-46F8-8EB9-4156969DB327Q33758003-C38BBB11-7EE5-44A9-B9BA-5612AEA06EEBQ33916128-CBEA2411-5B9D-4DD4-98CA-43C6EF52EEF1Q34297640-E1CED8AA-6F02-4DB3-9E50-9FC777D86CA2Q34394875-9A23F687-936B-4EF6-87AF-F7117B489CEDQ34395455-C3AA5400-FFD4-47B8-93EB-739A90C2998DQ34540864-62EBC2CD-56D7-4FF7-A4CB-E18058FC8BA0Q35039193-FA9E9DA7-3AEC-44FB-82FC-47F8CDB6E9BDQ35213569-B46BB211-55B5-48D3-8A44-144E501CD87BQ35250735-B26AB173-687F-4C9A-8B48-8C23F40041DFQ35345427-E98A2E99-1C0D-4C58-96A7-130B62FB0BACQ35432823-240A7A65-D538-420E-AD13-57301A82E655Q35529820-335B1F04-5114-4C17-9B98-9DDCEC67E04EQ35657780-23F5ADFA-D7DC-42BD-B894-073615FABE5BQ35744063-55239B7F-54DC-4892-BFEC-5FB47C1101E3Q35755057-FF64105E-347C-4667-A5F1-E3902E4257FBQ35848347-FB42C3C1-3E31-4A86-9D3E-D3C6D68D88AAQ35884212-07030BB6-6754-4775-8F80-10E8F822DE67Q35998332-9A748091-6A2B-4C0B-BB4E-23CB696A3FB8Q36021810-40C3E500-69A2-44D4-8CB1-F5CA09C0B150Q36202328-3ACE79C7-751F-4679-8F60-21CF39851AF4Q36411506-56478F00-1730-40E5-BD2A-37A44102F79FQ36551049-EAC767A8-6E92-4EEB-8E69-3054DDC01FB8Q36779008-3BA99A9C-F7A0-49DA-8078-148A2F386DC3
P2860
Control and surveillance of human African trypanosomiasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Control and surveillance of human African trypanosomiasis.
@en
Control and surveillance of human African trypanosomiasis.
@nl
type
label
Control and surveillance of human African trypanosomiasis.
@en
Control and surveillance of human African trypanosomiasis.
@nl
prefLabel
Control and surveillance of human African trypanosomiasis.
@en
Control and surveillance of human African trypanosomiasis.
@nl
P1476
Control and surveillance of human African trypanosomiasis.
@en
P577
2013-01-01T00:00:00Z